Avanos Medical Stock Probability Of Bankruptcy

AVNS Stock

USD 19.03 0.57 2.91%

Avanos Medical's odds of distress is under 27% at this time. It has slight probability of undergoing some form of financial straits in the near future. Avanos Medical's Probability of financial unrest is determined by interpolating and adjusting Avanos Altman Z Score to account for off-balance-sheet items and missing or unfiled public information. All items used in analyzing the odds of distress are taken from the Avanos balance sheet, as well as cash flow and income statements available from the company's most recent filings. Check out Avanos Medical Piotroski F Score and Avanos Medical Altman Z Score analysis.

For more information on how to buy Avanos Stock please use our How to Invest in Avanos Medical guide.

Enterprise Value is likely to gain to about 2.3 B in 2024, whereas Market Cap is likely to drop slightly above 1.4 B in 2024.

Avanos Medical Company probability of financial unrest Analysis

Avanos Medical's Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

Probability Of Bankruptcy

Normalized

Z-Score

More About Probability Of Bankruptcy | All Equity Analysis

Current Avanos Medical Probability Of Bankruptcy

Less than 27%

Most of Avanos Medical's fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Avanos Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Our calculation of Avanos Medical probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Avanos Medical odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Avanos Medical financial health.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avanos Medical. If investors know Avanos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avanos Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.38)

Earnings Share

0.47

Revenue Per Share

14.791

Quarterly Revenue Growth

(0.01)

Return On Assets

0.0208

The market value of Avanos Medical is measured differently than its book value, which is the value of Avanos that is recorded on the company's balance sheet. Investors also form their own opinion of Avanos Medical's value that differs from its market value or its book value, called intrinsic value, which is Avanos Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avanos Medical's market value can be influenced by many factors that don't directly affect Avanos Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Avanos Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Avanos Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avanos Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Avanos Probability Of Bankruptcy Driver Correlations

Understanding the fundamental principles of building solid financial models for Avanos Medical is extremely important. It helps to project a fair market value of Avanos Stock properly, considering its historical fundamentals such as Probability Of Bankruptcy. Since Avanos Medical's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Avanos Medical's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Avanos Medical's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Tangible Assets	Retained Earnings	Accounts Payable	Long Term Debt	Net Receivables	Good Will	Total Liab	Deferred Long Term Liab	Short Long Term Debt	Total Current Assets	Treasury Stock	Short Term Debt	Intangible Assets	Common Stock	Property Plant Equipment	Current Deferred Revenue	Net Debt	Long Term Debt Total	Capital Surpluse	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.91	0.0	-0.19	0.78	0.84	0.94	0.95	0.75	0.2	0.19	0.81	0.01	0.22	0.63	0.88	0.88	0.16	0.35	0.02	-0.03	0.06	0.03	0.08
Total Stockholder Equity	0.91		0.06	-0.06	0.53	0.68	0.81	0.92	0.44	0.01	-0.08	0.64	-0.13	-0.03	0.68	0.84	0.85	0.09	0.01	-0.14	0.11	-0.15	-0.14	-0.1
Net Tangible Assets	0.0	0.06		-0.55	-0.08	-0.45	0.02	-0.2	-0.07	0.11	-0.4	0.28	-0.68	-0.4	0.46	0.35	-0.33	0.71	-0.29	-0.85	0.53	-0.71	-0.79	-0.17
Retained Earnings	-0.19	-0.06	-0.55		-0.29	0.04	-0.36	0.02	-0.42	-0.76	-0.5	-0.41	0.53	-0.5	-0.47	-0.53	-0.05	-0.96	-0.36	0.52	-0.45	0.51	0.52	0.28
Accounts Payable	0.78	0.53	-0.08	-0.29		0.82	0.82	0.67	0.9	0.28	0.49	0.85	0.3	0.48	0.29	0.63	0.64	0.22	0.54	0.26	-0.27	0.28	0.31	0.14
Long Term Debt	0.84	0.68	-0.45	0.04	0.82		0.82	0.84	0.78	0.13	0.43	0.69	0.45	0.45	0.21	0.55	0.84	-0.16	0.53	0.54	-0.39	0.5	0.54	0.18
Net Receivables	0.94	0.81	0.02	-0.36	0.82	0.82		0.87	0.84	0.32	0.32	0.84	-0.03	0.34	0.58	0.88	0.83	0.31	0.52	0.01	0.02	-0.02	0.0	-0.07
Good Will	0.95	0.92	-0.2	0.02	0.67	0.84	0.87		0.62	0.05	0.15	0.62	0.09	0.19	0.53	0.78	0.95	-0.05	0.28	0.11	-0.09	0.11	0.1	0.08
Total Liab	0.75	0.44	-0.07	-0.42	0.9	0.78	0.84	0.62		0.47	0.55	0.82	0.16	0.54	0.33	0.65	0.59	0.32	0.81	0.22	-0.13	0.23	0.23	0.09
Deferred Long Term Liab	0.2	0.01	0.11	-0.76	0.28	0.13	0.32	0.05	0.47		0.62	0.31	-0.41	0.62	0.5	0.42	0.1	0.7	0.52	-0.17	0.45	-0.19	-0.21	-0.26
Short Long Term Debt	0.19	-0.08	-0.4	-0.5	0.49	0.43	0.32	0.15	0.55	0.62		0.18	0.28	1.0	-0.08	0.16	0.35	0.26	0.64	0.37	-0.25	0.34	0.36	0.14
Total Current Assets	0.81	0.64	0.28	-0.41	0.85	0.69	0.84	0.62	0.82	0.31	0.18		-0.02	0.19	0.52	0.77	0.5	0.41	0.43	0.0	0.02	0.0	0.04	-0.06
Treasury Stock	0.01	-0.13	-0.68	0.53	0.3	0.45	-0.03	0.09	0.16	-0.41	0.28	-0.02		0.27	-0.62	-0.39	0.17	-0.68	0.16	0.87	-0.81	0.88	0.9	0.5
Short Term Debt	0.22	-0.03	-0.4	-0.5	0.48	0.45	0.34	0.19	0.54	0.62	1.0	0.19	0.27		-0.04	0.19	0.39	0.26	0.62	0.36	-0.23	0.32	0.35	0.13
Intangible Assets	0.63	0.68	0.46	-0.47	0.29	0.21	0.58	0.53	0.33	0.5	-0.08	0.52	-0.62	-0.04		0.83	0.43	0.59	0.0	-0.58	0.59	-0.52	-0.61	-0.26
Common Stock	0.88	0.84	0.35	-0.53	0.63	0.55	0.88	0.78	0.65	0.42	0.16	0.77	-0.39	0.19	0.83		0.72	0.56	0.27	-0.4	0.37	-0.37	-0.39	-0.19
Property Plant Equipment	0.88	0.85	-0.33	-0.05	0.64	0.84	0.83	0.95	0.59	0.1	0.35	0.5	0.17	0.39	0.43	0.72		-0.05	0.31	0.18	-0.17	0.16	0.16	0.1
Current Deferred Revenue	0.16	0.09	0.71	-0.96	0.22	-0.16	0.31	-0.05	0.32	0.7	0.26	0.41	-0.68	0.26	0.59	0.56	-0.05		0.2	-0.69	0.6	-0.68	-0.69	-0.39
Net Debt	0.35	0.01	-0.29	-0.36	0.54	0.53	0.52	0.28	0.81	0.52	0.64	0.43	0.16	0.62	0.0	0.27	0.31	0.2		0.36	-0.15	0.29	0.32	0.04
Long Term Debt Total	0.02	-0.14	-0.85	0.52	0.26	0.54	0.01	0.11	0.22	-0.17	0.37	0.0	0.87	0.36	-0.58	-0.4	0.18	-0.69	0.36		-0.7	0.91	0.98	0.32
Capital Surpluse	-0.03	0.11	0.53	-0.45	-0.27	-0.39	0.02	-0.09	-0.13	0.45	-0.25	0.02	-0.81	-0.23	0.59	0.37	-0.17	0.6	-0.15	-0.7		-0.8	-0.78	-0.72
Net Invested Capital	0.06	-0.15	-0.71	0.51	0.28	0.5	-0.02	0.11	0.23	-0.19	0.34	0.0	0.88	0.32	-0.52	-0.37	0.16	-0.68	0.29	0.91	-0.8		0.95	0.66
Net Working Capital	0.03	-0.14	-0.79	0.52	0.31	0.54	0.0	0.1	0.23	-0.21	0.36	0.04	0.9	0.35	-0.61	-0.39	0.16	-0.69	0.32	0.98	-0.78	0.95		0.44
Capital Stock	0.08	-0.1	-0.17	0.28	0.14	0.18	-0.07	0.08	0.09	-0.26	0.14	-0.06	0.5	0.13	-0.26	-0.19	0.1	-0.39	0.04	0.32	-0.72	0.66	0.44

Click cells to compare fundamentals

The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.

Competition

Predict Avanos Medical

Based on the latest financial disclosure, Avanos Medical has a Probability Of Bankruptcy of 27.0%. This is 37.63% lower than that of the Health Care Equipment & Supplies sector and 34.42% lower than that of the Health Care industry. The probability of bankruptcy for all United States stocks is 32.21% higher than that of the company.

Avanos Probability Of Bankruptcy Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Avanos Medical's direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Avanos Medical could also be used in its relative valuation, which is a method of valuing Avanos Medical by comparing valuation metrics of similar companies.

Avanos Medical is currently under evaluation in probability of bankruptcy category among its peers.

Avanos Medical Main Bankruptcy Drivers

	2019	2020	2021	2022	2023	2024 (projected)
Return On Assets	(0.0255)	(0.0163)	0.003951	0.0283	(0.0365)	(0.0347)
Asset Turnover	0.39	0.43	0.47	0.46	0.4	0.58
Gross Profit Margin	0.6	0.58	0.52	0.49	0.56	0.37
Net Debt	120.1M	137.3M	69M	152.3M	121.4M	148.1M
Total Current Liabilities	212.5M	166.3M	139.2M	185.8M	234.6M	200.5M
Non Current Liabilities Total	321.9M	250M	191.5M	309.9M	221.5M	288.4M
Total Assets	1.8B	1.7B	1.6B	1.8B	1.7B	1.5B
Total Current Assets	538.5M	467.2M	418.6M	499.8M	487M	627.7M
Total Cash From Operating Activities	(74.5M)	(2.5M)	87.3M	90.9M	32.4M	30.8M

Avanos Medical ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Avanos Medical's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Avanos Medical's managers, analysts, and investors.

Environmental

Governance

Social

Avanos Fundamentals

	Return On Equity	0.0177
	Return On Asset	0.0208
	Profit Margin	0.02 %
	Operating Margin	0.1 %
	Current Valuation	1.01 B
	Shares Outstanding	45.96 M
	Shares Owned By Insiders	2.94 %
	Shares Owned By Institutions	96.07 %
	Number Of Shares Shorted	552.33 K
	Price To Earning	51.23 X
	Price To Book	0.71 X
	Price To Sales	1.28 X
	Revenue	673.3 M
	Gross Profit	450 M
	EBITDA	50.6 M
	Net Income	(61.8 M)
	Cash And Equivalents	106.5 M
	Cash Per Share	2.26 X
	Total Debt	209.1 M
	Debt To Equity	0.24 %
	Current Ratio	2.89 X
	Book Value Per Share	26.73 X
	Cash Flow From Operations	32.4 M
	Short Ratio	2.14 X
	Earnings Per Share	0.47 X
	Price To Earnings To Growth	2.29 X
	Target Price	22.5
	Number Of Employees	3.77 K
	Beta	0.93
	Market Capitalization	874.56 M
	Total Asset	1.69 B
	Retained Earnings	(314.9 M)
	Working Capital	252.4 M
	Current Asset	773.54 M
	Current Liabilities	415.63 M
	Net Asset	1.69 B

About Avanos Medical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Avanos Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Avanos Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Avanos Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Avanos Stock Analysis

When running Avanos Medical's price analysis, check to measure Avanos Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Avanos Medical is operating at the current time. Most of Avanos Medical's value examination focuses on studying past and present price action to predict the probability of Avanos Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Avanos Medical's price. Additionally, you may evaluate how the addition of Avanos Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Avanos Medical Stock Probability Of Bankruptcy

Avanos Medical Company probability of financial unrest Analysis

Probability Of Bankruptcy

Normalized

Z-Score

Current Avanos Medical Probability Of Bankruptcy

Avanos Probability Of Bankruptcy Driver Correlations

Avanos Probability Of Bankruptcy Peer Comparison

Avanos Medical Main Bankruptcy Drivers

Avanos Medical ESG Sustainability

Avanos Fundamentals

About Avanos Medical Fundamental Analysis

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Avanos Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY